Status:

COMPLETED

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure

Lead Sponsor:

Medtronic - MITG

Conditions:

Colonic Diseases

Eligibility:

All Genders

18-75 years

Brief Summary

The purpose of this study is to compare two preparation and procedure in order to develop the most optimal capsule procedure in regards to colon cleansing level and capsule excretion rate.

Detailed Description

The evaluation of subjects with suspected colonic disease includes endoscopic imaging by colonoscopy and radiologic imaging such as air-contrast barium enema, or CT colonography. The PillCam platform ...

Eligibility Criteria

Inclusion

  • Subject is between the ages of 18-75 years.
  • Subject is referred for colonoscopy as clinically indicated for any reason. This may include, but not limited to, the investigation of any of the following conditions: rectal bleeding, melena, positive stool testing for occult blood, recent change of bowel habits, screening for colorectal cancer, ulcerative colitis, colonic findings on an imaging study)

Exclusion

  • The presence of any of the following will exclude a subject from study enrollment:
  • Subject has dysphagia or any swallowing disorder
  • Subject has Congestive heart failure
  • Subject has high degree of renal insufficiency
  • Subject has had prior abdominal surgery of the gastrointestinal tract other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator
  • Subject has a cardiac pacemaker or other implanted electromedical device.
  • Subject has any allergy or other known contraindication to the medications used in the study
  • Subject is expected to undergo MRI examination within 7 days after ingestion of the capsule.
  • Subject with any condition believed to have an increased risk for capsule retention such as Crohn's disease, intestinal tumors, radiation enteritis, or NSAID enteropathy,
  • Subject has any condition, which precludes compliance with study and/or device instructions.
  • Women who are either pregnant or nursing at the time of screening, who intend to be during the study period, or are of child-bearing potential and do not practice medically acceptable methods of contraception.
  • Subject suffers from life threatening conditions
  • Subject currently participating in another clinical study

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2009

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00885339

Start Date

February 1 2008

End Date

October 1 2009

Last Update

July 31 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Centro Ricerca e Formazione ad Alta Tecnologia nelle Scienze Bomediche

Campobasso, Italy, 86100

2

Humanitas Istituto Clinico

Milan, Italy, 20089

3

Ospedale Maggiore - Policlinico

Milan, Italy, 2100

4

Universita Cattolica del Sacro Cuore

Roma, Italy, 00168